Global Serplulimab Injection market size is predicted to grow from US$ 5.9 million in 2025 to US$ 60.3 million in 2031; it is expected to grow at a CAGR of 47.5% from 2025 to 2031.

Global Serplulimab Injection Market Trends, Growth and Outlook 2025-31

The global Serplulimab Injection market size is predicted to grow from US$ 5.9 million in 2025 to US$ 60.3 million in 2031; it is expected to grow at a CAGR of 47.5% from 2025 to 2031. Serplulimab(also known as HLX 10) is a recombinant, humanised, anti-PD1 monoclonal antibody, being developed by Shanghai Henlius Biotech. United States market for Serplulimab Injection is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. China market for Serplulimab Injection is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Europe market for Serplulimab Injection is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Global key Serplulimab Injection players cover Shanghai Henlius Biotech, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024. Infinity Market Research newest research report, the Serplulimab Injection Industry Forecast looks at past sales and reviews total world Serplulimab Injection sales in 2024, providing a comprehensive analysis by region and market sector of projected Serplulimab Injection sales for 2025 through 2031. With Serplulimab Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Serplulimab Injection industry. This Insight Report provides a comprehensive analysis of the global Serplulimab Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Serplulimab Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Serplulimab Injection market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Serplulimab Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Serplulimab Injection. This report presents a comprehensive overview, market shares, and growth opportunities of Serplulimab Injection market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; 100mg/10ml &nbsp;&nbsp;&nbsp; Others Segmentation by Application: &nbsp;&nbsp;&nbsp; Hospitals &nbsp;&nbsp;&nbsp; Clinics &nbsp;&nbsp;&nbsp; Others This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Shanghai Henlius Biotech Key Questions Addressed in this Report What is the 10-year outlook for the global Serplulimab Injection market? What factors are driving Serplulimab Injection market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Serplulimab Injection market opportunities vary by end market size? How does Serplulimab Injection break out by Type, by Application?

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Serplulimab Injection Annual Sales 2020-2031 &nbsp;2.1.2 World Current & Future Analysis for Serplulimab Injection by Geographic Region, 2020, 2024 & 2031 &nbsp;2.1.3 World Current & Future Analysis for Serplulimab Injection by Country/Region, 2020, 2024 & 2031 &nbsp;2.2 Serplulimab Injection Segment by Type &nbsp;2.2.1 100mg/10ml &nbsp;2.2.2 Others &nbsp;2.3 Serplulimab Injection Sales by Type &nbsp;2.3.1 Global Serplulimab Injection Sales Market Share by Type (2020-2025) &nbsp;2.3.2 Global Serplulimab Injection Revenue and Market Share by Type (2020-2025) &nbsp;2.3.3 Global Serplulimab Injection Sale Price by Type (2020-2025) &nbsp;2.4 Serplulimab Injection Segment by Application &nbsp;2.4.1 Hospitals &nbsp;2.4.2 Clinics &nbsp;2.4.3 Others &nbsp;2.5 Serplulimab Injection Sales by Application &nbsp;2.5.1 Global Serplulimab Injection Sale Market Share by Application (2020-2025) &nbsp;2.5.2 Global Serplulimab Injection Revenue and Market Share by Application (2020-2025) &nbsp;2.5.3 Global Serplulimab Injection Sale Price by Application (2020-2025) 3 Global by Company &nbsp;3.1 Global Serplulimab Injection Breakdown Data by Company &nbsp;3.1.1 Global Serplulimab Injection Annual Sales by Company (2020-2025) &nbsp;3.1.2 Global Serplulimab Injection Sales Market Share by Company (2020-2025) &nbsp;3.2 Global Serplulimab Injection Annual Revenue by Company (2020-2025) &nbsp;3.2.1 Global Serplulimab Injection Revenue by Company (2020-2025) &nbsp;3.2.2 Global Serplulimab Injection Revenue Market Share by Company (2020-2025) &nbsp;3.3 Global Serplulimab Injection Sale Price by Company &nbsp;3.4 Key Manufacturers Serplulimab Injection Producing Area Distribution, Sales Area, Product Type &nbsp;3.4.1 Key Manufacturers Serplulimab Injection Product Location Distribution &nbsp;3.4.2 Players Serplulimab Injection Products Offered &nbsp;3.5 Market Concentration Rate Analysis &nbsp;3.5.1 Competition Landscape Analysis &nbsp;3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.6 New Products and Potential Entrants &nbsp;3.7 Market M&A Activity & Strategy 4 World Historic Review for Serplulimab Injection by Geographic Region &nbsp;4.1 World Historic Serplulimab Injection Market Size by Geographic Region (2020-2025) &nbsp;4.1.1 Global Serplulimab Injection Annual Sales by Geographic Region (2020-2025) &nbsp;4.1.2 Global Serplulimab Injection Annual Revenue by Geographic Region (2020-2025) &nbsp;4.2 World Historic Serplulimab Injection Market Size by Country/Region (2020-2025) &nbsp;4.2.1 Global Serplulimab Injection Annual Sales by Country/Region (2020-2025) &nbsp;4.2.2 Global Serplulimab Injection Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Serplulimab Injection Sales Growth &nbsp;4.4 APAC Serplulimab Injection Sales Growth &nbsp;4.5 Europe Serplulimab Injection Sales Growth &nbsp;4.6 Middle East & Africa Serplulimab Injection Sales Growth 5 Americas &nbsp;5.1 Americas Serplulimab Injection Sales by Country &nbsp;5.1.1 Americas Serplulimab Injection Sales by Country (2020-2025) &nbsp;5.1.2 Americas Serplulimab Injection Revenue by Country (2020-2025) &nbsp;5.2 Americas Serplulimab Injection Sales by Type (2020-2025) &nbsp;5.3 Americas Serplulimab Injection Sales by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Serplulimab Injection Sales by Region &nbsp;6.1.1 APAC Serplulimab Injection Sales by Region (2020-2025) &nbsp;6.1.2 APAC Serplulimab Injection Revenue by Region (2020-2025) &nbsp;6.2 APAC Serplulimab Injection Sales by Type (2020-2025) &nbsp;6.3 APAC Serplulimab Injection Sales by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia &nbsp;6.10 China Taiwan 7 Europe &nbsp;7.1 Europe Serplulimab Injection by Country &nbsp;7.1.1 Europe Serplulimab Injection Sales by Country (2020-2025) &nbsp;7.1.2 Europe Serplulimab Injection Revenue by Country (2020-2025) &nbsp;7.2 Europe Serplulimab Injection Sales by Type (2020-2025) &nbsp;7.3 Europe Serplulimab Injection Sales by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Serplulimab Injection by Country &nbsp;8.1.1 Middle East & Africa Serplulimab Injection Sales by Country (2020-2025) &nbsp;8.1.2 Middle East & Africa Serplulimab Injection Revenue by Country (2020-2025) &nbsp;8.2 Middle East & Africa Serplulimab Injection Sales by Type (2020-2025) &nbsp;8.3 Middle East & Africa Serplulimab Injection Sales by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Manufacturing Cost Structure Analysis &nbsp;10.1 Raw Material and Suppliers &nbsp;10.2 Manufacturing Cost Structure Analysis of Serplulimab Injection &nbsp;10.3 Manufacturing Process Analysis of Serplulimab Injection &nbsp;10.4 Industry Chain Structure of Serplulimab Injection 11 Marketing, Distributors and Customer &nbsp;11.1 Sales Channel &nbsp;11.1.1 Direct Channels &nbsp;11.1.2 Indirect Channels &nbsp;11.2 Serplulimab Injection Distributors &nbsp;11.3 Serplulimab Injection Customer 12 World Forecast Review for Serplulimab Injection by Geographic Region &nbsp;12.1 Global Serplulimab Injection Market Size Forecast by Region &nbsp;12.1.1 Global Serplulimab Injection Forecast by Region (2026-2031) &nbsp;12.1.2 Global Serplulimab Injection Annual Revenue Forecast by Region (2026-2031) &nbsp;12.2 Americas Forecast by Country (2026-2031) &nbsp;12.3 APAC Forecast by Region (2026-2031) &nbsp;12.4 Europe Forecast by Country (2026-2031) &nbsp;12.5 Middle East & Africa Forecast by Country (2026-2031) &nbsp;12.6 Global Serplulimab Injection Forecast by Type (2026-2031) &nbsp;12.7 Global Serplulimab Injection Forecast by Application (2026-2031) 13 Key Players Analysis &nbsp;13.1 Shanghai Henlius Biotech &nbsp;13.1.1 Shanghai Henlius Biotech Company Information &nbsp;13.1.2 Shanghai Henlius Biotech Serplulimab Injection Product Portfolios and Specifications &nbsp;13.1.3 Shanghai Henlius Biotech Serplulimab Injection Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.1.4 Shanghai Henlius Biotech Main Business Overview &nbsp;13.1.5 Shanghai Henlius Biotech Latest Developments 14 Research Findings and Conclusion

Report	Global Serplulimab Injection Market Growth 2025-2031
Selected License	Multi ID: LPI38873

Buyer Information

Order Summary